{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:10:48Z","timestamp":1791274248675,"version":"4.1.0"},"reference-count":121,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>This review examines the effects of gender-affirming hormone therapy (GAHT) on kidney health in transgender and gender diverse (TGD) populations, which face significant challenges in accessing medical care. GAHT typically involves estrogen therapy for transgender women and transfeminine individuals, testosterone therapy for transgender men and transmasculine individuals, and therapy regimens for individuals who are nonbinary or identify with another gender not culturally assigned to their sex assigned at birth. Hormone therapy influences biomarkers such as creatinine and cystatin C, which are used in eGFR. Current eGFR equations, reliant on sex-specific factors, may misrepresent kidney function in TGD individuals, leading to misdiagnosis or misclassification of kidney disease stages. GAHT alters serum creatinine (SCr) and cystatin C differently in individuals who use masculinizing or feminizing hormones. Testosterone therapy often raises SCr, while estrogen therapy may lower or has no effect on SCr levels. In addition, GAHT can affect CKD progression and the incidence of AKI due to a myriad of factors including hormonal effects. Estrogen may offer renal protection, while testosterone may elevate risks. Clearly, more data are needed, especially concerning the long-term effects of GAHT on CKD and AKI incidence and progression among TGD individuals. Kidney transplant considerations for TGD patients are complex, involving factors such as the effect of hormone therapy on allograft and patient survivals, drug-drug interactions, and unique anatomical challenges The lack of inclusive data in kidney disease registries and national databases for TGD populations limits the understanding of the effect of GAHT on kidney health. This narrative review calls for comprehensive and longitudinal research to better define eGFR estimation in TGD individuals using GAHT and the broader implications of GAHT on kidney health outcomes.<\/jats:p>","DOI":"10.2215\/cjn.0000000886","type":"journal-article","created":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T16:07:55Z","timestamp":1757088475000},"page":"154-171","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Kidney Health and Gender-Affirming Hormone Therapy for Transgender and Gender Diverse Individuals"],"prefix":"10.2215","volume":"21","author":[{"given":"Patel","family":"Reema","sequence":"first","affiliation":[{"name":"Department of Endocrinology, VA Greater Los Angeles Health Care System, Los Angeles, California"},{"name":"UCLA Division of Endocrinology, Diabetes and Metabolism, David Geffen School of Medicine, University of California, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shira","family":"Grock","sequence":"additional","affiliation":[{"name":"UCLA Division of Endocrinology, Diabetes and Metabolism, David Geffen School of Medicine, University of California, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8834-1560","authenticated-orcid":false,"given":"Hill L.","family":"Wolfe","sequence":"additional","affiliation":[{"name":"Department of Biomedical Informatics and Data Science, Yale School of Medicine, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9515-5050","authenticated-orcid":false,"given":"Nicholas","family":"Jackson","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine and Health Services Research, Department of Medicine at UCLA, David Geffen School of Medicine, University of California, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Neugarten","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Nephrology, Albert Einstein College of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Hashemi","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Department of Medicine, VA Greater Los Angeles Health Care System, Los Angeles, California"},{"name":"Division of General Internal Medicine, Department of Medicine at UCLA, David Geffen School of Medicine, University of California, Los Angeles, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,5]]},"reference":[{"issue":"8","key":"B1-20260318","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/jamainternmed.2018.7931","article-title":"Findings from the behavioral risk factor surveillance system on health-related quality of life among US transgender adults, 2014-2017","volume":"179","author":"Baker","year":"2019","journal-title":"JAMA Intern Med."},{"issue":"11","key":"B2-20260318","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an endocrine society clinical practice guideline","volume":"102","author":"Hembree","year":"2017","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"B3-20260318","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.3390\/jcm9061609","article-title":"Hormonal treatment strategies tailored to non-binary transgender individuals","volume":"9","author":"Cocchetti","year":"2020","journal-title":"J Clin Med."},{"issue":"4","key":"B4-20260318","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1089\/lgbt.2016.0099","article-title":"Coverage for gender-affirming care: making health insurance work for transgender americans","volume":"4","author":"Padula","year":"2017","journal-title":"LGBT Health."},{"issue":"4","key":"B5-20260318","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s11606-015-3529-6","article-title":"Societal implications of health insurance coverage for medically necessary services in the U.S. transgender population: a cost-effectiveness analysis","volume":"31","author":"Padula","year":"2016","journal-title":"J Gen Intern Med."},{"issue":"1","key":"B6-20260318","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1089\/trgh.2016.0031","article-title":"Identifying the transgender population in the medicare program","volume":"1","author":"Proctor","year":"2016","journal-title":"Transgend Health."},{"key":"B7-20260318","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.socscimed.2015.11.010","article-title":"Transgender stigma and health: a critical review of stigma determinants, mechanisms, and interventions","volume":"147","author":"White Hughto","year":"2015","journal-title":"Soc Sci Med."},{"issue":"2","key":"B8-20260318","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MED.0000000000000229","article-title":"Advancing methods for US transgender health research","volume":"23","author":"Reisner","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes."},{"key":"B9-20260318","doi-asserted-by":"crossref","first-page":"102985","DOI":"10.1016\/j.healthplace.2023.102985","article-title":"Mapping transgender policies in the US 2017-2021: the role of geography and implications for health equity","volume":"80","author":"Kline","year":"2023","journal-title":"Health Place."},{"issue":"suppl 1","key":"B10-20260318","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1080\/26895269.2022.2100644","article-title":"Standards of care for the health of transgender and gender diverse people, version 8","volume":"23","author":"Coleman","year":"2022","journal-title":"Int J Transgender Health."},{"key":"B11-20260318","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/978-3-319-70178-3_27","article-title":"Sex, gender, and transgender: metabolic impact of cross hormone therapy","volume":"1043","author":"de Souza Santos","year":"2017","journal-title":"Adv Exp Med Biol."},{"issue":"1","key":"B12-20260318","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2215\/CJN.03030320","article-title":"Gender and CKD: beyond the binary","volume":"16","author":"Ahmed","year":"2020","journal-title":"Clin J Am Soc Nephrol."},{"issue":"3","key":"B13-20260318","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/QAI.0b013e31826a6c4f","article-title":"Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals","volume":"61","author":"Inker","year":"2012","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"1","key":"B14-20260318","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med."},{"issue":"2","key":"B15-20260318","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1053\/j.ajkd.2024.01.522","article-title":"A holistic framework for the evaluation of kidney function in a gender-diverse landscape","volume":"84","author":"Turino Miranda","year":"2024","journal-title":"Am J Kidney Dis."},{"issue":"3","key":"B16-20260318","doi-asserted-by":"crossref","first-page":"151284","DOI":"10.1016\/j.semnephrol.2022.10.010","article-title":"Does gender affirming hormone therapy increase the risk of kidney disease?","volume":"42","author":"Eckenrode","year":"2022","journal-title":"Semin Nephrol."},{"issue":"4","key":"B17-20260318","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.kint.2024.06.030","article-title":"Glomerular filtration rate estimation in transgender and gender-diverse adults using gender-affirming hormone therapy: an exploratory cross-sectional study","volume":"106","author":"Turino Miranda","year":"2024","journal-title":"Kidney Int."},{"issue":"3","key":"B18-20260318","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4239\/wjd.v11.i3.66","article-title":"Effects of gender-affirming hormone therapy on insulin resistance and body composition in transgender individuals: a systematic review","volume":"11","author":"Spanos","year":"2020","journal-title":"World J Diabetes."},{"issue":"5","key":"B19-20260318","doi-asserted-by":"crossref","first-page":"e12660","DOI":"10.1111\/and.12660","article-title":"Cross-sex hormone therapy in transgender persons affects total body weight, body fat and lean body mass: a meta-analysis","volume":"49","author":"Klaver","year":"2017","journal-title":"Andrologia."},{"issue":"5","key":"B20-20260318","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ki.1985.205","article-title":"Limitations of creatinine as a filtration marker in glomerulopathic patients","volume":"28","author":"Shemesh","year":"1985","journal-title":"Kidney Int."},{"issue":"7","key":"B21-20260318","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1093\/ndt\/gfs571","article-title":"A possible role of cystatin C in adipose tissue homeostasis may impact kidney function estimation in metabolic syndrome","volume":"28","author":"de Vries","year":"2013","journal-title":"Nephrol Dial Transplant."},{"issue":"1","key":"B22-20260318","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/jalm\/jfaa192","article-title":"Dynamic impact of hormone therapy on laboratory values in transgender patients over time","volume":"6","author":"Allen","year":"2021","journal-title":"J Appl Lab Med."},{"issue":"5","key":"B23-20260318","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/ejendo\/lvad052","article-title":"Changes in laboratory results in transgender individuals on hormone therapy - a retrospective study and practical approach","volume":"188","author":"Boekhout-Berends","year":"2023","journal-title":"Eur J Endocrinol."},{"issue":"2","key":"B24-20260318","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.amjmed.2013.10.009","article-title":"Interpreting laboratory results in transgender patients on hormone therapy","volume":"127","author":"Roberts","year":"2014","journal-title":"Am J Med."},{"issue":"1","key":"B25-20260318","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1373\/clinchem.2018.292730","article-title":"Impact of hormone therapy on laboratory values in transgender patients","volume":"65","author":"SoRelle","year":"2019","journal-title":"Clin Chem."},{"issue":"3","key":"B26-20260318","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/00045632211066777","article-title":"Reference intervals for biochemical analytes in transgender individuals on hormone therapy","volume":"59","author":"Bezuidenhout","year":"2022","journal-title":"Ann Clin Biochem."},{"issue":"7","key":"B27-20260318","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1177\/10600280211050120","article-title":"A retrospective analysis of creatinine-based kidney function with and without sex assigned at birth among transgender adults","volume":"56","author":"Fadich","year":"2022","journal-title":"Ann Pharmacother."},{"issue":"4","key":"B28-20260318","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4158\/EP15950.OR","article-title":"Metabolic effects of hormone therapy in transgender patients","volume":"22","author":"Fernandez","year":"2016","journal-title":"Endocr Pract."},{"issue":"2","key":"B29-20260318","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000135710","article-title":"Effects of sex steroids on the neurotransmitter-specific aromatic amino acids phenylalanine, tyrosine, and tryptophan in transsexual subjects","volume":"88","author":"Giltay","year":"2008","journal-title":"Neuroendocrinology."},{"issue":"2","key":"B30-20260318","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1210\/jcem.83.2.4574","article-title":"Effects of sex steroids on plasma total homocysteine levels: a study in transsexual males and females","volume":"83","author":"Giltay","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"B31-20260318","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1373\/jalm.2018.027078","article-title":"Common hormone therapies used to care for transgender patients influence laboratory results","volume":"3","author":"Humble","year":"2019","journal-title":"J Appl Lab Med."},{"key":"B32-20260318","doi-asserted-by":"crossref","first-page":"20503121211051546","DOI":"10.1177\/20503121211051546","article-title":"Effects of testosterone treatment on transgender males: a single-institution study","volume":"9","author":"Korpaisarn","year":"2021","journal-title":"SAGE Open Med."},{"issue":"3","key":"B33-20260318","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/JCMA.0000000000000475","article-title":"Metabolic effects of cross-sex hormone therapy in transgender individuals in Taiwan","volume":"84","author":"Liu","year":"2021","journal-title":"J Chin Med Assoc."},{"issue":"1","key":"B34-20260318","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.eprac.2021.08.009","article-title":"The effect of gender-affirming hormone therapy on serum creatinine in transgender individuals","volume":"28","author":"Maheshwari","year":"2022","journal-title":"Endocr Pract."},{"issue":"7","key":"B35-20260318","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s00198-004-1754-7","article-title":"Cortical and trabecular bone mineral density in transsexuals after long-term cross-sex hormonal treatment: a cross-sectional study","volume":"16","author":"Ruetsche","year":"2005","journal-title":"Osteoporos Int."},{"key":"B36-20260318","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.maturitas.2017.10.012","article-title":"Changes in hormonal and metabolic parameters in transgender subjects on cross-sex hormone therapy: a cohort study","volume":"107","author":"Vita","year":"2018","journal-title":"Maturitas."},{"issue":"8","key":"B37-20260318","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/jsm.12571","article-title":"Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence","volume":"11","author":"Wierckx","year":"2014","journal-title":"J Sex Med."},{"issue":"9","key":"B38-20260318","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.2215\/CJN.01890222","article-title":"The effect of gender-affirming hormone therapy on measures of kidney function: a systematic review and meta-analysis","volume":"17","author":"Krupka","year":"2022","journal-title":"Clin J Am Soc Nephrol."},{"issue":"12","key":"B39-20260318","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.2215\/CJN.0000000000000289","article-title":"Cystatin C-based eGFR changes during gender-affirming hormone therapy in transgender individuals","volume":"18","author":"van Eeghen","year":"2023","journal-title":"Clin J Am Soc Nephrol."},{"issue":"1","key":"B40-20260318","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41581-019-0191-y","article-title":"Measured and estimated glomerular filtration rate: current status and future directions","volume":"16","author":"Levey","year":"2020","journal-title":"Nat Rev Nephrol."},{"issue":"6","key":"B41-20260318","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41581-024-00840-2","article-title":"Considerations of sex as a binary variable in clinical algorithms","volume":"20","author":"Mohottige","year":"2024","journal-title":"Nat Rev Nephrol."},{"key":"B42-20260318","doi-asserted-by":"crossref","first-page":"2054358120985379","DOI":"10.1177\/2054358120985379","article-title":"Providing care for transgender persons with kidney disease: a narrative review","volume":"8","author":"Collister","year":"2021","journal-title":"Can J Kidney Health Dis."},{"key":"B43-20260318","doi-asserted-by":"crossref","first-page":"20543581211020168","DOI":"10.1177\/20543581211020168","article-title":"Assessment of renal function in transgender patients with kidney disease","volume":"8","author":"Jue","year":"2021","journal-title":"Can J Kidney Health Dis."},{"issue":"1","key":"B44-20260318","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/jarr.2003.50001","article-title":"The role of gender in the progression of renal disease","volume":"10","author":"Silbiger","year":"2003","journal-title":"Adv Ren Replace Ther."},{"issue":"2","key":"B45-20260318","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1159\/000049033","article-title":"Effects of sex on renal structure","volume":"90","author":"Neugarten","year":"2002","journal-title":"Nephron."},{"issue":"11","key":"B46-20260318","first-page":"1145","article-title":"The impact of gender on renal transplantation","volume":"58","author":"Neugarten","year":"1994","journal-title":"Transplantation."},{"issue":"12","key":"B48-20260318","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1093\/gerona\/gls171","article-title":"Sexual dimorphism: the aging kidney, involvement of nitric oxide deficiency, and angiotensin II overactivity","volume":"67","author":"Baylis","year":"2012","journal-title":"J Gerontol A Biol Sci Med Sci."},{"issue":"4","key":"B49-20260318","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.exger.2005.01.008","article-title":"Changes in renal hemodynamics and structure in the aging kidney; sexual dimorphism and the nitric oxide system","volume":"40","author":"Baylis","year":"2005","journal-title":"Exp Gerontol."},{"issue":"4","key":"B50-20260318","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1681\/ASN.V94699","article-title":"The aging kidney: insights from experimental studies","volume":"9","author":"Baylis","year":"1998","journal-title":"J Am Soc Nephrol."},{"issue":"1","key":"B51-20260318","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MNH.0000000000000463","article-title":"Sex hormones and their influence on chronic kidney disease","volume":"28","author":"Valdivielso","year":"2019","journal-title":"Curr Opin Nephrol Hypertens."},{"issue":"6","key":"B52-20260318","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1093\/ndt\/13.6.1430","article-title":"Differences between women and men with chronic renal disease","volume":"13","author":"Coggins","year":"1998","journal-title":"Nephrol Dial Transplant."},{"issue":"2","key":"B53-20260318","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/sj.ki.5000058","article-title":"The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age","volume":"69","author":"Eriksen","year":"2006","journal-title":"Kidney Int."},{"issue":"13","key":"B54-20260318","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/0024-3205(87)90731-4","article-title":"Contrasting effects of early and late orchiectomy on hypertension and renal disease in fawn-hooded rats","volume":"41","author":"Gilboa","year":"1987","journal-title":"Life Sci."},{"issue":"5","key":"B55-20260318","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/S0002-9440(10)64277-0","article-title":"Estrogen deficiency accelerates progression of glomerulosclerosis in susceptible mice","volume":"162","author":"Elliot","year":"2003","journal-title":"Am J Pathol."},{"issue":"4","key":"B56-20260318","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0002-9440(10)63929-6","article-title":"Resistance to glomerulosclerosis in B6 mice disappears after menopause","volume":"162","author":"Zheng","year":"2003","journal-title":"Am J Pathol."},{"issue":"4","key":"B57-20260318","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1159\/000065442","article-title":"Different effects of castration and estrogen administration on glomerular injury in spontaneously hyperglycemic Otsuka Long-Evans Tokushima Fatty (OLETF) rats","volume":"92","author":"Tomiyoshi","year":"2002","journal-title":"Nephron."},{"issue":"2","key":"B58-20260318","doi-asserted-by":"crossref","first-page":"R769","DOI":"10.1152\/ajpregu.00375.2006","article-title":"17beta-estradiol supplementation reduces tubulointerstitial fibrosis by increasing MMP activity in the diabetic kidney","volume":"292","author":"Mankhey","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"issue":"5","key":"B59-20260318","doi-asserted-by":"crossref","first-page":"F1678","DOI":"10.1152\/ajprenal.00079.2007","article-title":"17beta-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-beta protein expression and signaling","volume":"293","author":"Dixon","year":"2007","journal-title":"Am J Physiol Renal Physiol."},{"issue":"6","key":"B60-20260318","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1016\/S0002-9440(10)62473-X","article-title":"Estrogen and raloxifene, a selective estrogen receptor modulator, ameliorate renal damage in db\/db mice","volume":"166","author":"Chin","year":"2005","journal-title":"Am J Pathol."},{"issue":"3","key":"B61-20260318","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/sj.ki.5002690","article-title":"Protective effect of 17beta-estradiol on ischemic acute renal failure through the PI3K\/Akt\/eNOS pathway","volume":"73","author":"Satake","year":"2008","journal-title":"Kidney Int."},{"issue":"6","key":"B62-20260318","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-118-6-199303150-00006","article-title":"Influence of sex hormones on plasma endothelin levels","volume":"118","author":"Polderman","year":"1993","journal-title":"Ann Intern Med."},{"issue":"50","key":"B63-20260318","doi-asserted-by":"crossref","first-page":"52282","DOI":"10.1074\/jbc.M407629200","article-title":"Testosterone is responsible for enhanced susceptibility of males to ischemic renal injury","volume":"279","author":"Park","year":"2004","journal-title":"J Biol Chem."},{"issue":"4","key":"B64-20260318","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ki.2010.398","article-title":"Testosterone and 17\u03b2-estradiol have opposite effects on podocyte apoptosis that precedes glomerulosclerosis in female estrogen receptor knockout mice","volume":"79","author":"Doublier","year":"2011","journal-title":"Kidney Int."},{"issue":"12","key":"B65-20260318","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1016\/j.mayocp.2020.10.013","article-title":"Gender and the progression of chronic kidney disease","volume":"95","author":"Neugarten","year":"2020","journal-title":"Mayo Clin Proc."},{"key":"B66-20260318","doi-asserted-by":"crossref","first-page":"823835","DOI":"10.3389\/fmed.2022.823835","article-title":"Early menopause may associate with a higher risk of CKD and all-cause mortality in postmenopausal women: an analysis of NHANES, 1999-2014","volume":"9","author":"Qian","year":"2022","journal-title":"Front Med (Lausanne)."},{"issue":"11","key":"B67-20260318","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.2215\/CJN.03990318","article-title":"CKD in patients with bilateral oophorectomy","volume":"13","author":"Kattah","year":"2018","journal-title":"Clin J Am Soc Nephrol."},{"issue":"3","key":"B68-20260318","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA."},{"issue":"6","key":"B69-20260318","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1681\/ASN.V76930","article-title":"Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin\/creatinine ratio","volume":"7","author":"Warram","year":"1996","journal-title":"J Am Soc Nephrol."},{"issue":"6","key":"B70-20260318","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/GME.0000000000001062","article-title":"Hormone therapy and urine protein excretion: a multiracial cohort study, systematic review, and meta-analysis","volume":"25","author":"Kattah","year":"2018","journal-title":"Menopause."},{"issue":"2","key":"B71-20260318","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2215\/CJN.04660421","article-title":"Kidney disease prevalence in transgender individuals","volume":"17","author":"Eckenrode","year":"2022","journal-title":"Clin J Am Soc Nephrol."},{"issue":"9","key":"B72-20260318","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.2215\/CJN.08280722","article-title":"Advancing kidney health equity: influences of gender-affirming hormone therapy on kidney function","volume":"17","author":"Mohottige","year":"2022","journal-title":"Clin J Am Soc Nephrol."},{"issue":"2","key":"B73-20260318","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.semnephrol.2022.04.010","article-title":"Sex differences in acute kidney injury","volume":"42","author":"Neugarten","year":"2022","journal-title":"Semin Nephrol."},{"issue":"1","key":"B74-20260318","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12882-018-0937-y","article-title":"Sex differences in acute kidney injury requiring dialysis","volume":"19","author":"Neugarten","year":"2018","journal-title":"BMC Nephrol."},{"issue":"4","key":"B75-20260318","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract."},{"issue":"1","key":"B76-20260318","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1213\/ane.0b013e318178ca42","article-title":"Renal ischemia: does sex matter?","volume":"107","author":"Hutchens","year":"2008","journal-title":"Anesth Analg."},{"issue":"6","key":"B77-20260318","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.3892\/mmr.2014.2089","article-title":"Effect of gender differences on the regulation of renal ischemia-reperfusion-induced inflammation in mice","volume":"9","author":"Kang","year":"2014","journal-title":"Mol Med Rep."},{"issue":"4","key":"B78-20260318","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/j.1523-1755.2002.kid590.x","article-title":"Sexual dimorphism in renal ischemia-reperfusion injury in rats: possible role of endothelin","volume":"62","author":"M\u00fcller","year":"2002","journal-title":"Kidney Int."},{"issue":"4","key":"B79-20260318","doi-asserted-by":"crossref","first-page":"F806","DOI":"10.1152\/ajprenal.00080.2006","article-title":"Sex differences in heat shock protein 72 expression and localization in rats following renal ischemia-reperfusion injury","volume":"291","author":"Fekete","year":"2006","journal-title":"Am J Physiol Renal Physiol."},{"issue":"3","key":"B80-20260318","doi-asserted-by":"crossref","first-page":"F377","DOI":"10.1152\/ajprenal.00354.2011","article-title":"Estrogen protects renal endothelial barrier function from ischemia-reperfusion in vitro and in vivo","volume":"303","author":"Hutchens","year":"2012","journal-title":"Am J Physiol Renal Physiol."},{"issue":"1","key":"B81-20260318","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0022-5347(06)00490-3","article-title":"Sex differences and the role of sex steroids in renal injury","volume":"176","author":"Metcalfe","year":"2006","journal-title":"J Urol."},{"issue":"2","key":"B82-20260318","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2215025","article-title":"Cardiovascular safety of testosterone-replacement therapy","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med."},{"issue":"3","key":"B83-20260318","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1001\/jama.2013.8638","article-title":"Androgen deprivation therapy and risk of acute kidney injury in patients with prostate cancer","volume":"310","author":"Lapi","year":"2013","journal-title":"JAMA."},{"issue":"6","key":"B84-20260318","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.eururo.2014.01.026","article-title":"Gonadotropin-releasing hormone agonists and acute kidney injury in patients with prostate cancer","volume":"66","author":"Gandaglia","year":"2014","journal-title":"Eur Urol."},{"issue":"3","key":"B85-20260318","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1053\/j.ajkd.2024.10.003","article-title":"Sex, acute kidney injury, and age: a prospective cohort study","volume":"85","author":"Golestaneh","year":"2025","journal-title":"Am J Kidney Dis."},{"issue":"1","key":"B86-20260318","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.kint.2024.08.034","article-title":"Female sex hormones inversely regulate acute kidney disease susceptibility throughout life","volume":"107","author":"Kitai","year":"2025","journal-title":"Kidney Int."},{"issue":"1","key":"B87-20260318","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12882-024-03614-x","article-title":"Sex bias in prediction and diagnosis of cardiac surgery associated acute kidney injury","volume":"25","author":"Demirjian","year":"2024","journal-title":"BMC Nephrol."},{"issue":"10","key":"B89-20260318","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1111\/ajt.15963","article-title":"Kidney transplantation and donation in the transgender population: a single-institution case series","volume":"20","author":"Ramadan","year":"2020","journal-title":"Am J Transplant."},{"issue":"1","key":"B90-20260318","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1526924816632132","article-title":"Cultural sensitivity and challenges in management of the transgender patient with ESRD in transplantation","volume":"26","author":"Hoch","year":"2016","journal-title":"Prog Transplant."},{"issue":"1","key":"B91-20260318","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11934-020-0953-x","article-title":"Kidney transplantation in transgender patients","volume":"21","author":"Jue","year":"2020","journal-title":"Curr Urol Rep."},{"key":"B92-20260318","doi-asserted-by":"crossref","first-page":"1360856","DOI":"10.3389\/fneph.2024.1360856","article-title":"Gender and kidney transplantation","volume":"4","author":"Nautiyal","year":"2024","journal-title":"Front Nephrol."},{"issue":"4","key":"B93-20260318","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/ndt\/gfad181","article-title":"Influence of donor sex and age on graft outcome in kidney transplantation","volume":"39","author":"Melk","year":"2024","journal-title":"Nephrol Dial Transplant."},{"issue":"7","key":"B94-20260318","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/TP.0000000000004026","article-title":"Age-dependent sex differences in graft loss after kidney transplantation","volume":"106","author":"Vinson","year":"2022","journal-title":"Transplantation."},{"issue":"10","key":"B95-20260318","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1111\/ajt.16611","article-title":"Recipient sex and estradiol levels affect transplant outcomes in an age-specific fashion","volume":"21","author":"Maenosono","year":"2021","journal-title":"Am J Transplant."},{"issue":"10","key":"B96-20260318","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1681\/ASN.2016121380","article-title":"Association of sex with risk of kidney graft failure differs by age","volume":"28","author":"Lepeytre","year":"2017","journal-title":"J Am Soc Nephrol."},{"issue":"10","key":"B97-20260318","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1097\/01.ASN.0000030078.74889.69","article-title":"The effect of donor gender on graft survival","volume":"13","author":"Zeier","year":"2002","journal-title":"J Am Soc Nephrol."},{"issue":"10","key":"B98-20260318","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.2215\/CJN.02310220","article-title":"Donor age, donor-recipient size mismatch, and kidney graft survival","volume":"15","author":"Lepeytre","year":"2020","journal-title":"Clin J Am Soc Nephrol."},{"issue":"2","key":"B99-20260318","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.semnephrol.2022.04.011","article-title":"Sex and gender differences in kidney transplantation","volume":"42","author":"Katz-Greenberg","year":"2022","journal-title":"Semin Nephrol."},{"issue":"5","key":"B100-20260318","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1172\/JCI84712","article-title":"Improved renal ischemia tolerance in females influences kidney transplantation outcomes","volume":"126","author":"Aufhauser","year":"2016","journal-title":"J Clin Invest."},{"issue":"2","key":"B101-20260318","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/phar.2656","article-title":"Race and sex associations with tacrolimus pharmacokinetics in stable kidney transplant recipients","volume":"42","author":"Tornatore","year":"2022","journal-title":"Pharmacotherapy."},{"issue":"4","key":"B102-20260318","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0009-9236(96)90112-5","article-title":"The effects of menopause and hormone replacement therapies on prednisolone and erythromycin pharmacokinetics","volume":"59","author":"Harris","year":"1996","journal-title":"Clin Pharmacol Ther."},{"issue":"11","key":"B103-20260318","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1177\/00912700122012733","article-title":"Prednisolone pharmacokinetics and pharmacodynamics in relation to sex and race","volume":"41","author":"Magee","year":"2001","journal-title":"J Clin Pharmacol."},{"issue":"3","key":"B104-20260318","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.trre.2017.02.003","article-title":"Sex differences in transplantation","volume":"31","author":"Momper","year":"2017","journal-title":"Transplant Rev (Orlando)."},{"issue":"5","key":"B105-20260318","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/00007691-200110000-00004","article-title":"In vivo higher glucuronidation of mycophenolic acid in male than in female recipients of a cadaveric kidney allograft and under immunosuppressive therapy with mycophenolate mofetil","volume":"23","author":"Morissette","year":"2001","journal-title":"Ther Drug Monit."},{"issue":"7","key":"B106-20260318","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1089\/152460902760360568","article-title":"Biologic and molecular mechanisms for sex differences in pharmacokinetics, pharmacodynamics, and pharmacogenetics: Part II","volume":"11","author":"Anthony","year":"2002","journal-title":"J Womens Health Gend Based Med."},{"key":"B107-20260318","doi-asserted-by":"crossref","first-page":"108711","DOI":"10.1016\/j.drugalcdep.2021.108711","article-title":"Transgender-related discrimination and substance use, substance use disorder diagnosis and treatment history among transgender adults","volume":"223","author":"Wolfe","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"B108-20260318","doi-asserted-by":"crossref","first-page":"115339","DOI":"10.1016\/j.psychres.2023.115339","article-title":"Prevalence of substance use and mental health problems among transgender and cisgender U.S. adults: results from a national probability sample","volume":"326","author":"Kidd","year":"2023","journal-title":"Psychiatry Res."},{"key":"B109-20260318","doi-asserted-by":"crossref","first-page":"106988","DOI":"10.1016\/j.ypmed.2022.106988","article-title":"Health, economic and social disparities among transgender women, transgender men and transgender nonbinary adults: results from a population-based study","volume":"156","author":"Fredriksen Goldsen","year":"2022","journal-title":"Prev Med."},{"issue":"4","key":"B110-20260318","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/MLR.0000000000001693","article-title":"Prevalence of private and public health insurance among transgender and gender diverse adults","volume":"60","author":"Downing","year":"2022","journal-title":"Med Care."},{"issue":"suppl 2","key":"B111-20260318","first-page":"3","article-title":"The evaluation of renal transplantation candidates: clinical practice guidelines","volume":"1","author":"Kasiske","year":"2001","journal-title":"Am J Transplant."},{"issue":"5","key":"B112-20260318","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/YCO.0000000000000185","article-title":"Psychiatric aspects of organ transplantation and donation","volume":"28","author":"Faeder","year":"2015","journal-title":"Curr Opin Psychiatry."},{"issue":"11","key":"B114-20260318","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/j.eprac.2024.08.014","article-title":"Evaluating the risk of venous thromboembolism in transfeminine and gender diverse people: a retrospective analysis","volume":"30","author":"Slack","year":"2024","journal-title":"Endocr Pract."},{"issue":"1","key":"B115-20260318","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1182\/hematology.2024000592","article-title":"Gender-affirming hormone therapy in the transgender patient: influence on thrombotic risk","volume":"2024","author":"King","year":"2024","journal-title":"Hematology Am Soc Hematol Educ Program."},{"issue":"6","key":"B116-20260318","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1370\/afm.2586","article-title":"Insurance coverage and use of hormones among transgender respondents to a national survey","volume":"18","author":"Stroumsa","year":"2020","journal-title":"Ann Fam Med."},{"issue":"5","key":"B117-20260318","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1370\/afm.3018","article-title":"Erythrocytosis in gender-affirming care with testosterone","volume":"21","author":"Porat","year":"2023","journal-title":"Ann Fam Med."},{"issue":"6","key":"B118-20260318","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1210\/clinem\/dgab089","article-title":"Erythrocytosis in a large cohort of trans men using testosterone: a long-term follow-up study on prevalence, determinants, and exposure years","volume":"106","author":"Madsen","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"B119-20260318","doi-asserted-by":"crossref","first-page":"220","DOI":"10.5500\/wjt.v11.i6.220","article-title":"Post-transplant erythrocytosis after kidney transplantation: a review","volume":"11","author":"Alzoubi","year":"2021","journal-title":"World J Transplant."},{"issue":"4","key":"B120-20260318","first-page":"277","article-title":"Interaction between estradiol and tacrolimus in kidney-transplanted menopausal women","volume":"1","author":"Migali","year":"2008","journal-title":"NDT Plus."},{"issue":"2","key":"B121-20260318","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/trgh.2022.0040","article-title":"Patient characteristics associated with receiving gender-affirming hormone therapy in the veterans health administration","volume":"9","author":"Wolfe","year":"2024","journal-title":"Transgend Health."},{"issue":"2","key":"B122-20260318","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S2055-6640(20)30475-1","article-title":"Transgender populations and HIV: unique risks, challenges and opportunities","volume":"2","author":"Wansom","year":"2016","journal-title":"J Virus Erad."},{"issue":"suppl 3","key":"B123-20260318","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1097\/QAI.0000000000001087","article-title":"Global epidemiology of HIV infection and related syndemics affecting transgender people","volume":"72","author":"Poteat","year":"2016","journal-title":"J Acquir Immune Defic Syndr."},{"key":"B124-20260318","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3389\/fpsyt.2020.00106","article-title":"Psychological and psychopathological aspects of kidney transplantation: a systematic review","volume":"11","author":"De Pasquale","year":"2020","journal-title":"Front Psychiatry."}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000000886","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:47:12Z","timestamp":1786369632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.0000000886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,5]]},"references-count":121,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.0000000886","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,5]]}}}